Osteoarthritis

You have full text access to this OnlineOpen article

Effect of hyaluronic acid in symptomatic hip osteoarthritis: A multicenter, randomized, placebo-controlled trial†

  1. Pascal Richette1,
  2. Philippe Ravaud2,‡,
  3. Thierry Conrozier3,§,
  4. Liana Euller-Ziegler4,
  5. Bernard Mazières5,
  6. Yves Maugars6,
  7. Denis Mulleman7,
  8. Pierre Clerson8,¶,
  9. Xavier Chevalier9,‖,*

Article first published online: 26 FEB 2009

DOI: 10.1002/art.24301

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 60, Issue 3, pages 824–830, March 2009

Additional Information

How to Cite

Richette, P., Ravaud, P., Conrozier, T., Euller-Ziegler, L., Mazières, B., Maugars, Y., Mulleman, D., Clerson, P. and Chevalier, X. (2009), Effect of hyaluronic acid in symptomatic hip osteoarthritis: A multicenter, randomized, placebo-controlled trial. Arthritis & Rheumatism, 60: 824–830. doi: 10.1002/art.24301

Author Information

  1. 1

    Hôpital Lariboisière, Assistance Publique Hôpitaux de Paris, Paris, France

  2. 2

    INSERM U738, Hôpital Bichat, Assistance Publique Hôpitaux de Paris, Paris, France

  3. 3

    CHU Hôpital Lyon Sud, Pierre Bénite, France

  4. 4

    CHU Hôpital Archet I, Nice, France

  5. 5

    CHU Hôpital Rangueil, Toulouse, France

  6. 6

    CHU Hôtel Dieu, Nantes, France

  7. 7

    Hopital Trousseau, Tours, France

  8. 8

    Orgametric, Roubaix, France

  9. 9

    Hôpital Henri-Mondor, Assistance Publique Hôpitaux de Paris, Créteil, France

  1. ‡

    Dr. Ravaud has received consulting fees, speaking fees, and/or honoraria from Servier, Roche, Daiichi Sankyo, Pfizer, Sanofi, Schering-Plough, and Almirall (less than $10,000 each).

  2. §

    Dr. Conrozier has received consulting fees, speaking fees, and/or honoraria from Genome and Bristol-Myers Squibb (less than $10,000 each) and from Pfizer and Smith & Nephew (more than $10,000 each).

  3. Dr. Clerson has received consulting fees, speaking fees, and/or honoraria from Daiichi Sankyo, Actelion, Janssen, Takeda, and Bayer Schering (more than $10,000 each).

  4. ‖

    Dr. Chevalier has received consulting fees, speaking fees, and/or honoraria from Expanscience, Pfizer, Genzyme, Servier, Sankyo, Rottapharma, and Fidia (less than $10,000 each).

*Department of Rheumatology, Hôpital Henri-Mondor, 94010 Créteil Cedex, France

  1. †

    ClinicalTrials.gov identifier: NCT00330135.

Publication History

  1. Issue published online: 26 FEB 2009
  2. Article first published online: 26 FEB 2009
  3. Manuscript Accepted: 7 NOV 2008
  4. Manuscript Received: 16 MAY 2008

Funded by

  • Daiichi Sankyo France

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (85K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A. Borrás-Verdera, V. Calcedo-Bernal, J. Ojeda-Levenfeld, C. Clavel-Sainz, Eficacia y seguridad de una única inyección intraarticular de ácido hialurónico al 2% más manitol en artrosis de rodilla durante un periodo de 6 meses, Revista Española de Cirugía Ortopédica y Traumatología, 2012,

    CrossRef

  2. 2
    Sascha Colen, Daniel Haverkamp, Michiel Mulier, Michel P.J. van den Bekerom, Hyaluronic Acid for the Treatment of Osteoarthritis in all Joints Except the Knee, BioDrugs, 2012, 26, 2, 101

    CrossRef

  3. 3
    Farah Hameed, Joseph Ihm, Injectable Medications for Osteoarthritis, PM&R, 2012, 4, 5, S75

    CrossRef

  4. 4
    N. Bonin, F. Laude, D. Mainard, J.-M. Ferret, L. Bellaiche, K.-A. Siebenrock, V. Legré, T. Boyer, J.-E. Gédouin, M. Lesquene, P. Tanji, Sport et vieillissement articulaire avec arthrose précoce et conflit antérieur de hanche, Revue de Chirurgie Orthopédique et Traumatologique, 2012, 98, 3, 312

    CrossRef

  5. 5
    Pascal Richette, Approches thérapeutiques de l’arthrose, Thérapie, 2011, 66, 5, 383

    CrossRef

  6. 6
    Benjamin G. Domb, Craig J. McAsey, Cartilage Injuries in the Degenerative Hip, Operative Techniques in Sports Medicine, 2011, 19, 2, 129

    CrossRef

  7. 7
    C. de Jaeger, P. Cherin, L’arthrose : une nouvelle maladie inflammatoire ? Actualités fondamentales et thérapeutiques, Médecine & Longévité, 2011, 3, 3, 116

    CrossRef

  8. 8
    James A. Browne, The Mature Athlete with Hip Arthritis, Clinics in Sports Medicine, 2011, 30, 2, 453

    CrossRef

  9. 9
    M. Sanchez, J. Guadilla, N. Fiz, I. Andia, Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip, Rheumatology, 2011, 51, 1, 144

    CrossRef

  10. 10
    Michele Abate, Arthritis, 2011,

    CrossRef

  11. 11
    Ali Mobasheri, Constance Aldinger, Mehdi Shakibaei, Inflammation, Lifestyle and Chronic Diseases, 2011,

    CrossRef

  12. 12
    Robert C. Manske, Cullen M. Nigrini, S. Brent Brotzman, Clinical Orthopaedic Rehabilitation, 2011,

    CrossRef

  13. 13
    P. Ornetti, S. Parratte, L. Gossec, C. Tavernier, J.-N. Argenson, E.M. Roos, F. Guillemin, J.F. Maillefert, Cross-cultural adaptation and validation of the French version of the Hip disability and Osteoarthritis Outcome Score (HOOS) in hip osteoarthritis patients, Osteoarthritis and Cartilage, 2010, 18, 4, 522

    CrossRef

  14. 14
    Nicolò Martinelli, Umile Giuseppe Longo, Andrea Marinozzi, Edoardo Franceschetti, Vincenzo Costa, Vincenzo Denaro, Cross-cultural adaptation and validation with reliability, validity, and responsiveness of the Italian version of the Oxford Hip Score in patients with hip osteoarthritis, Quality of Life Research, 2010, 20, 6, 923

    CrossRef

  15. 15
    Antonio Gigante, Leonardo Callegari, The role of intra-articular hyaluronan (Sinovial®) in the treatment of osteoarthritis, Rheumatology International, 2010, 31, 4, 427

    CrossRef

  16. 16
    Lisa A. Mandl, Robert N. Hotchkiss, Ronald S. Adler, Stephen Lyman, Aaron Daluiski, Scott W. Wolfe, Jeffrey N. Katz, Injectable hyaluronan for the treatment of carpometacarpal osteoarthritis: open label pilot trial, Current Medical Research and Opinion, 2009, 25, 9, 2103

    CrossRef

  17. 17
    David J. Hunter, Osteoarthritis: Hyaluronic acid is not effective in symptomatic hip OA, Nature Reviews Rheumatology, 2009, 5, 7, 359

    CrossRef

  18. 18
    P. Ornetti, A.V. Perruccio, E.M. Roos, L.S. Lohmander, A.M. Davis, J.F. Maillefert, Psychometric properties of the French translation of the reduced KOOS and HOOS (KOOS-PS and HOOS-PS), Osteoarthritis and Cartilage, 2009, 17, 12, 1604

    CrossRef

View Full Article (HTML) Get PDF (85K)